SEC ownership of Burning Rock Biotech Ltd

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001792267.

Comparable stake leader

Kynam Capital Management, LP

Disclosed value leader

Yusheng Han

Comparable rows

17/21

Latest evidence

30 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
17 of 21
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Kynam Capital Management, LP
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001792267
Issuer location
Guangzhou, Guangdong

Ownership snapshot

Top shareholders of Burning Rock Biotech Ltd (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Kynam Capital Management, LP
Disclosed value leader
Yusheng Han
Comparable rows
17/21
Latest evidence
30 Jun 2026
13F 13D/G 3/4/5 Lead comparable stake: 14% 4 rows are not safely comparable across share classes. 13D/G row: Kynam Capital Management, LP Showing 1-8 of 21 holder rows.

Quick read

Kynam Capital Management, LP leads the comparable SEC ownership view at 14%.

17 of 21 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Kynam Capital Management, LP's linked filing trail.
Comparable ownership Top 5
Kynam Capital Management, LP 14%
CRCM LP 3.2%
RENAISSANCE TECHNOLOGIES LLC 0.6%
MORGAN STANLEY 0.49%
Amova Asset Management Americas, ... 0.34%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 21 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Kynam Capital Management, LP
13F 13D/G
Company
14%
from 13D/G
$10,517,747
1,238,563 shares
30 Jun 2026
CRCM LP
13D/G 13F
Company
3.2%
$4,581,255
282,097 shares
-$3,318,303 31 Mar 2026
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
0.6%
$442,254
52,838 shares
30 Jun 2026
MORGAN STANLEY
13F
Company
13F
0.49%
$364,882
43,594 shares
30 Jun 2026
Amova Asset Management Americas, Inc.
13F
Company
13F
0.34%
$257,707
29,724 shares
30 Jun 2026
Sumitomo Mitsui Trust Group, Inc.
13F
Company
13F
0.34%
$248,790
29,724 shares
30 Jun 2026
BANK OF AMERICA CORP /DE/
13F
Company
13F
0.33%
$244,103
29,164 shares
30 Jun 2026
CITADEL ADVISORS LLC
13F
Company
13F
0.31%
$236,587
27,288 shares
30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$11,648,315.

Buys
$11,648,315
Insiders: 1
Sells
$0
Insiders: 0
Net
+$11,648,315
Shares: +1,046,280
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 1,046,280 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 731,410 0 $6,182,172 $0 +$6,182,172
3-6 314,870 0 $5,466,143 $0 +$5,466,143
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-6 of 6 reporting-owner rows connected to Burning Rock Biotech Ltd. Open a relationship link for the CIK-to-CIK filing trail.

Rows
6
Largest Forms 3/4/5 holder
Yusheng Han
Net 12M change
+$11,648,315
Latest report
11 Jun 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Yusheng Han Director $147,151,710 +$11,648,315 +8.6% Filing P/S 11 Jun 2026
Licen Lisa Xu Director Mixed 17 Mar 2026
Xiaozhi Hu Senior Director in Finance Mixed 17 Mar 2026
Zhihong Zhang Director Mixed 17 Mar 2026
Wendy W. Hayes Director Mixed 17 Mar 2026
Feng Deng Director Mixed 18 Mar 2026

Recent insider transactions for Burning Rock Biotech Ltd

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Yusheng Han BNR Ordinary Shares (represented by American depositary shares) Purchase 0.14% $199,090 $8.00 24,900 18,404,086 26 Jun 2026 Direct
Yusheng Han BNR Ordinary Shares (represented by American depositary shares) Purchase 1.38% $2,000,000 $8.00 250,000 18,379,186 24 Jun 2026 Direct
Yusheng Han BNR Ordinary Shares (represented by American depositary shares) Purchase 0.03% $44,920 $7.50 5,990 18,129,186 23 Jun 2026 Direct
Yusheng Han BNR Ordinary Shares (represented by American depositary shares) Purchase 0.58% $779,674 $7.45 104,650 18,123,196 22 Jun 2026 Direct
Yusheng Han BNR Ordinary Shares (represented by American depositary shares) Purchase 0.62% $999,957 $9.00 111,110 18,018,546 16 Jun 2026 Direct
Yusheng Han BNR Ordinary Shares (represented by American depositary shares) Purchase 1.19% $1,942,143 $9.25 210,000 17,907,436 12 Jun 2026 Direct
Yusheng Han BNR Ordinary Shares (represented by American depositary shares) Purchase 0.14% $216,388 $8.74 24,760 17,697,436 11 Jun 2026 Direct
Yusheng Han BNR Ordinary Shares (represented by American depositary shares) Purchase 1.81% $5,466,143 $17.36 314,870 17,672,676 31 Mar 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .